Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 10:18:10 2024-05-29 EDT 		5-day change 1st Jan Change
0.921 EUR -2.23% Intraday chart for Lavipharm S.A. -4.06% +15.70%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
Lavipharm S.A. Auditor Raises 'Going Concern' Doubt
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. News Lavipharm S.A.
  5. Other languages